Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients-Reference-Cited by-同舟云学术

Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients

Published:2007-07 Issue:1 Volume:33 Page:91-98
ISSN:0740-5472
Container-title:Journal of Substance Abuse Treatment
language:en
Short-container-title:Journal of Substance Abuse Treatment

Author:

Maremmani Icro,Pani Pier Paolo,Pacini Matteo,Perugi Giulio

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology,Medicine (miscellaneous),Pshychiatric Mental Health

Reference65 articles.

1. Quality of life assessment in clinical trials: Methodologic issues;Aaronson;Controlled Clinical Trials,1989

2. Pharmacokinetics of liquid vs tablet buprenorphine;Ajir,1998

3. Diagnostic and statistical manual of mental disorders, DSM-IV (4th ed.);American Psychiatric Association,1994

4. The reduction of intravenous heroin use, non-opiate abuse and crime during methadone maintenance treatment: Further findings;Ball;NIDA Research Monograph,1988

5. The effectiveness of methadone maintenance treatment;Ball,1991

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial;Contemporary Clinical Trials;2024-07

2. The impact of State of Surrender on the relationship between engagement in substance use treatment and meaning in life presence: a pilot study;Frontiers in Psychology;2024-06-17

3. Quality of life and associated factors of heroin‐dependent patients receiving methadone and buprenorphine maintenance treatment;Neuropsychopharmacology Reports;2023-12

4. Quality of life of patients treated with opium tincture or methadone: A randomized controlled trial;Drug and Alcohol Dependence;2023-08

5. EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors;Frontiers in Psychiatry;2023-06-30